Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.
Glioblastomas are the most common primary central nervous system tumors in adults, and they remain resistant to current treatments. erbB1 signaling is frequently altered in glioblastomas, suggesting thaterbB receptor family members may represent targets for molecular therapy. We performed a comprehensive analysis of erbB receptor and ligand expression profiles in a panel of 9 glioblastomas andcompared them to nonneoplastic cerebral tissue containing neocortex and adjacent white matter. Quantitative reverse transcription-polymerase chain reaction and Western blot analysis showed that erbB1signaling and erbB2 receptors exhibited highly variable deregulation profiles in the tumors, with patterns ranging from underexpression to overexpression; in contrast, erbB3 and erbB4 were downregulated. We next performed immunohistochemistry to determinethe distribution patterns of erbB receptors among the main neuralcell types in the tumors with special reference to the putative tumor stem cell population. Results revealed intertumoral and intratumoral heterogeneity in all 4 erbB expression profiles, but each receptor exhibited a distinct distribution pattern among glial fibrillary acidic protein-, Olig2-, NeuN-, and CD133-positive populations. Although erbB1 immunoreactivity was detected in only small subsets of CD133-positive putative tumor stem cells, erbB3 immunoreactivity was prominent in this population, suggesting that erbB3 may represent a new potential therapeutic target.
Duhem-Tonnelle
Véronique
V
Inserm U837, Bâtiment Biserte, Place de Verdun, 59045 Lille Cedex, France.
Bièche
Ivan
I
Vacher
Sophie
S
Loyens
Anne
A
Maurage
Claude-Alain
CA
Collier
Francis
F
Baroncini
Marc
M
Blond
Serge
S
Prevot
Vincent
V
Sharif
Ariane
A
D000071916:AC133 Antigen; D000293:Adolescent; D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000378:metabolism; D015153:Blotting, Western; D001932:Brain Neoplasms / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000378:metabolism*; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D005260:Female; D005455:Fluorescent Antibody Technique; D015972:Gene Expression Regulation, Neoplastic; D005904:Glial Fibrillary Acidic Protein / Q000235:genetics / Q000378:metabolism; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D014411:Neoplastic Stem Cells; D010455:Peptides / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000378:metabolism; D020893:Receptor, ErbB-3 / Q000235:genetics / Q000378:metabolism*; D012044:Regression Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction
D000071916:AC133 Antigen; D015703:Antigens, CD; D066246:ErbB Receptors; D005904:Glial Fibrillary Acidic Protein; D006023:Glycoproteins; D010455:Peptides; D012333:RNA, Messenger; D018719:Erb-b2 Receptor Tyrosine Kinases; D020893:Receptor, ErbB-3; C000606023:PROM1 protein, human
Exp Cell Res. 2003 Mar 10;284(1):54-65
12648465
J Neuropathol Exp Neurol. 2004 May;63(5):499-509
15198128
J Neurooncol. 1994;22(3):201-7
7760096
Nature. 2006 Dec 7;444(7120):756-60
17051156
J Neuropathol Exp Neurol. 2003 Oct;62(10):1052-9
14575240
Zentralbl Pathol. 1994 Nov;140(4-5):335-41
7826981
J Neurosci Res. 2005 Feb 1;79(3):295-302
15605376
Growth Factors. 2006 Jun;24(2):121-36
16801132
Am J Pathol. 1991 Jul;139(1):67-79
1713022
J Neurooncol. 2007 Dec;85(3):281-7
17571214
Acta Neuropathol. 1998 Oct;96(4):322-8
9796995
J Histochem Cytochem. 1999 Feb;47(2):229-36
9889258
Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):147-56
15110798
Breast Cancer Res Treat. 2006 Jan;95(1):17-27
16267617
Am J Pathol. 2004 May;164(5):1717-25
15111318
Int J Cancer. 2003 Sep 20;106(5):758-65
12866037
Oncogene. 2007 Apr 26;26(19):2695-706
17057735
J Biol Chem. 2008 Apr 18;283(16):10958-66
18292095
Cancer Res. 2002 Jun 1;62(11):3151-8
12036928
Cancer. 1996 Sep 15;78(6):1272-83
8826951
Neurosurgery. 2004 Dec;55(6):1377-91: discussion 1391-2
15574220
J Neurosci. 2001 Jul 1;21(13):4740-51
11425901
Eur J Cancer. 1992;28(1):11-7
1567659
J Biol Chem. 2009 Mar 13;284(11):7138-48
19147502
Neurosurgery. 1999 Dec;45(6):1442-53
10598712
Int J Cancer. 2003 Mar 10;104(1):19-27
12532415
Brain Pathol. 2003 Jan;13(1):52-61
12580545
Am J Physiol Cell Physiol. 2008 May;294(5):C1242-9
18337564
Nature. 2004 Nov 18;432(7015):396-401
15549107
Prog Neurobiol. 2000 Dec;62(5):443-73
10869779
EMBO J. 1998 Jun 15;17(12):3385-97
9628875
Hum Pathol. 1994 Aug;25(8):772-80
7914508
J Biol Chem. 1997 Jan 31;272(5):2927-35
9006938
Acta Neuropathol. 2004 Aug;108(2):135-42
15148612
Glia. 2003 Jul;43(1):37-43
12761864
Oncogene. 2006 Jul 6;25(29):4076-85
16532035
Clin Cancer Res. 2005 Jul 1;11(13):4701-6
16000564
Cell. 2002 Sep 20;110(6):669-72
12297041
Cancer Res. 2006 Jan 15;66(2):867-74
16424019
Nat Neurosci. 2003 Nov;6(11):1127-34
14583753
Curr Opin Neurobiol. 2001 Jun;11(3):287-96
11399426
J Biol Chem. 1996 Aug 16;271(33):20047-52
8702723
Glia. 1995 Nov;15(3):211-21
8586458
Clin Cancer Res. 1998 Oct;4(10):2383-90
9796969
Neuropathol Appl Neurobiol. 2005 Aug;31(4):384-94
16008822
Nature. 2007 Jan 25;445(7126):437-41
17206155
J Clin Neurosci. 2007 Dec;14(12):1199-206
17964790
Glia. 2009 Mar;57(4):362-79
18803307
J Exp Clin Cancer Res. 2007 Sep;26(3):353-9
17987795
Neuron. 2005 Mar 24;45(6):873-86
15797549
N Engl J Med. 2008 Jul 31;359(5):492-507
18669428
Nature. 2004 Nov 18;432(7015):281-2
15549078
J Neurooncol. 1997 Dec;35(3):303-14
9440027
Neuropathol Appl Neurobiol. 2005 Feb;31(1):62-9
15634232
Am J Clin Oncol. 2003 Aug;26(4):332-5
12902879
Glia. 2005 Aug 15;51(3):217-28
15812817
Clin Cancer Res. 2006 Dec 15;12(24):7261-70
17189397
Cancer Invest. 2004;22(4):537-44
15565811
Glia. 2006 Dec;54(8):850-60
16981197
J Neurosurg. 1993 Feb;78(2):240-51
8093625
J Clin Neurosci. 2002 Mar;9(2):165-9
11922706
J Neuroendocrinol. 2007 Sep;19(9):691-702
17680884
Int J Cancer. 1994 Jan 2;56(1):72-7
8262681
Histopathology. 2006 Mar;48(4):438-44
16487366
J Neurosci. 1999 Nov 15;19(22):9913-27
10559400